Air India has launched a mandatory screening programme for all pilots across its group, testing for substances and medications prohibited under aviation regulations, sources confirmed on Thursday, 13 August. The move, which goes beyond existing regulatory requirements, follows an incident last week in which the pilot in command of an Air India flight from Phuket to Delhi was found to have been taking medication for sleep difficulty when the aircraft experienced a sudden loss of altitude.

What the Screening Programme Covers

According to a communication addressed to pilots, the testing programme commenced on 13 August and covers all group pilots without exception. The screening will be conducted at multiple locations — alongside training sessions at the Gurugram Academy, after flights at Flight Briefing Centres and Air India offices, and at designated locations across pilots' operating bases. Participation is mandatory.

What Air India Said

In its communication to pilots, the Tata Group-owned carrier stated that it already complies fully with all requirements prescribed by the Directorate General of Civil Aviation (DGCA), which it noted are broadly aligned with practices in major aviation markets including Europe and the United States. However, the airline said it had chosen to go further. 'Accordingly, we have decided to undertake a full screening of all Group pilots for any substances or medications that are not permitted under prevailing regulations,' the communication read.

The airline also acknowledged that many pilots had proactively reached out to express support for stronger safety measures. 'Many of you have recently reached out to share the same sentiment,' the airline noted in the letter.

The Phuket Flight Incident

The trigger for the initiative was a flight operating from Phuket to New Delhi that experienced a sudden loss of altitude last week. It subsequently emerged that the pilot in command had been taking medication for sleep difficulty — a disclosure that raised questions about compliance with existing fitness-to-fly standards and prompted the airline to act swiftly. The DGCA is the nodal regulator for pilot medical fitness in India, and its rules restrict the use of certain medications during active flying duty.

Significance and Industry Context

This is a notable instance of an Indian carrier voluntarily exceeding regulatory minimums on pilot health compliance. Air India described the initiative as reflecting its 'commitment to maintaining the highest standards of safety and professionalism while providing reassurance to passengers, stakeholders and the wider community.' Pilots with queries have been directed to contact their chief pilot or base manager. This comes amid broader scrutiny of aviation safety standards in India, where the DGCA has faced periodic criticism over enforcement gaps. A self-initiated, carrier-wide screening of this scale is rare in the domestic industry.

What Happens Next

The screening is ongoing and will be integrated into routine operational touchpoints rather than conducted as a one-time exercise. Industry observers will watch whether the DGCA uses this episode to tighten mandatory standards across all Indian carriers, or whether Air India's voluntary step remains an outlier.